LBA1 | THE BENEFIT OF POLA‐R‐CHP IN DLBclass‐DEFINED MOLECULAR SUBSETS OF NEWLY DIAGNOSED DLBCL IN THE POLARIX TRIALEleonora Calabretta, Margaret A. Shipp, Maria C. Palazzo et al.|Hematological Oncology|2025Cited by 9
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC studyMarta Bravo Peña, Alberto Mussetti, Giulia Losi et al.|Blood Advances|2026Cited by 1